AT A GLANCE
- % Free PSA = (Free PSA ÷ Total PSA) × 100 — the percentage of total PSA that is not bound to blood proteins
- Low % free PSA is the concerning finding — counterintuitively, a lower percentage suggests higher cancer probability
- Above 25% — generally associated with lower cancer probability; often reassuring in the context of total PSA 4–10 ng/mL
- Below 10% — associated with substantially elevated cancer probability in the same total PSA range
- The test is most useful when total PSA is 4–10 ng/mL (the "gray zone") — at very low total PSA, the percentage may not be clinically meaningful
- A "Low" (L) flag on your free PSA result does not mean your PSA number is low — it means your % free PSA is below the lab's reference range, which may indicate increased cancer risk
- Free PSA is different from total PSA — free PSA measures just the unbound fraction; total PSA is the sum of all forms
- Interpret all results alongside total PSA, age, DRE findings, family history, and prior PSA trends.
% FREE PSA AT A GLANCE: WHAT DOES YOUR NUMBER MEAN?
| % Free PSA | Cancer probability estimate | Risk interpretation | Typical next step |
|---|---|---|---|
| > 25% | ~9–16% (age-dependent) | Lower cancer probability | Active monitoring; biopsy often deferred |
| 18–25% | ~18–30% | Intermediate | Urologist review; MRI often considered |
| 10–17% | ~30–40% | Elevated concern | Urologist referral; biopsy discussion |
| < 10% | ~50–65% | High concern | Urologist referral; further workup typically warranted |
Valid when total PSA is 4–10 ng/mL. Below this total PSA range, % free PSA is less clinically reliable.
There is no single universal normal value for % free PSA. The percentage must be interpreted alongside total PSA level and age. The following thresholds are the most widely used in clinical practice:
% Free PSA Interpretation (when Total PSA is 4–10 ng/mL)
| % Free PSA | Cancer risk estimate | Clinical guidance |
|---|---|---|
| > 25% | ~8–16% | Generally lower risk; biopsy often deferred |
| 10–25% | ~18–34% | Intermediate; decision depends on age, DRE, and other factors |
| < 10% | ~50–65% | Substantially elevated risk; urologist referral and biopsy discussion typically warranted |
Age-specific cancer risk by % free PSA (Men with total PSA 4–10 ng/mL and non-suspicious DRE — Roche E602 immunoassay system)
| % Free PSA | Age 50–59 | Age 60–69 | Age ≥70 |
|---|---|---|---|
| ≤10% | 49.2% | 57.5% | 64.5% |
| 11–18% | 26.9% | 33.9% | 40.8% |
| 19–25% | 18.3% | 23.9% | 29.7% |
| >25% | 9.1% | 12.2% | 15.8% |
Key observations from this table:
- At the same % free PSA, cancer risk increases with age
- A 70-year-old with 12% free PSA has roughly the same cancer probability as a 60-year-old with 9% free PSA
- A result above 25% in a 60-year-old carries ~12% cancer probability — not zero, but substantially lower than at ≤10%
These are probability estimates, not certainties. A positive biopsy can occur at any % free PSA level.
WHAT DO "PSA FREE 14L," "PSA FREE 17," "PSA FREE 20L" MEAN?
Many lab reports express free PSA as a percentage, and some flag results below a reference threshold with an "L" (Low) designation. This is a common source of confusion.
What the "L" flag means: On lab reports and online portal displays like LabCorp and Quest, "L" after a PSA result means the value is below the lab's reference range for that measurement — it does not mean the absolute PSA number is low. For % free PSA, a LOW flag means the percentage is below the lower reference limit, which in clinical context means the free PSA proportion is reduced — the pattern associated with higher cancer risk.
Common lab report formats and what they mean:
PSA FREE 14L = Free PSA is 14% — flagged Low (below reference range) PSA FREE 17 = Free PSA is 17% — may or may not be flagged depending on lab PSA FREE 18 = Free PSA is 18% — borderline; interpret with total PSA and age PSA FREE 20L = Free PSA is 20% — flagged Low at some labs (cutoff >25%) PSA FREE 25L = Free PSA is 25% — flagged Low at labs using higher cutoff PSA FREE PCT = Free PSA percent (same measurement) PSA FREE PCT LOW = % free PSA below lab reference range PSA, % FREE = Standard LabCorp label for % free PSA PSA % FREE (CALC) = Calculated from separately measured free and total PSA values FREE/TOTAL PSA RATIO = Same measurement expressed as a decimal (e.g., 0.14 = 14%)
What specific percentages mean:
| % Free PSA | Typical interpretation in gray-zone total PSA (4–10 ng/mL) |
|---|---|
| 14% | Mildly-moderately reduced; intermediate-elevated cancer risk; discuss biopsy decision with urologist |
| 17% | Intermediate; elevated risk relative to >25% benchmark |
| 18% | Intermediate; discuss clinical context, age, and DRE with urologist |
| 20% | Lower end of intermediate; may be flagged Low depending on lab cutoff |
| 25% | At the commonly used 25% threshold; approximately 12% cancer probability in 60–69 age group |
WHAT TO DO NEXT
Based on your % free PSA result (when total PSA is 4–10 ng/mL):
- Above 25%, non-suspicious DRE, stable total PSA — Generally lower cancer probability. Many urologists would defer immediate biopsy and monitor PSA trends every 6–12 months. Shared decision-making with your urologist is appropriate.
- 10–25%, total PSA 4–10 ng/mL — Intermediate risk. Clinical decision-making should incorporate age, DRE findings, family history, PSA velocity, and patient preference. MRI before biopsy is increasingly used in this zone to identify lesions worth targeting.
- Below 10%, total PSA 4–10 ng/mL — Substantially elevated cancer risk. Urologist referral and biopsy discussion are typically appropriate. A prostate MRI may help characterise any lesions and guide targeted biopsy.
- Result flagged "Low" (L) on your lab report — This means your % free PSA is below the reference range, consistent with the lower end of the spectrum. The clinical significance depends on your total PSA, age, and DRE. Discuss with your doctor.
- Low % free PSA with normal total PSA (below 4 ng/mL) — Less common pattern. May represent early-stage cancer, biological variation, or assay variability. Warrants clinical assessment rather than immediate biopsy — repeat testing, MRI, or urologist evaluation is appropriate.
- % free PSA result when total PSA is below 2 ng/mL — At very low total PSA levels, the free PSA percentage calculation may not be clinically meaningful. Interpret with caution.
- High % free PSA (above 25%) — Generally reassuring. Suggests benign prostate enlargement (BPH) is a more likely cause of PSA elevation than cancer. Biopsy may reasonably be deferred; continue routine monitoring.
FREE PSA vs TOTAL PSA: WHAT'S THE DIFFERENCE?
PSA (prostate-specific antigen) circulates in the blood in two forms:
| Total PSA | Free PSA | % Free PSA | |
|---|---|---|---|
| What it measures | Sum of all PSA forms | PSA circulating unbound | Free PSA as % of total |
| Units | ng/mL | ng/mL | % |
| Cancer signal direction | High = more concerning | Low free fraction = concerning | Low % = more concerning |
| Most useful range | All PSA levels for initial screening | In combination with total PSA | Total PSA 4–10 ng/mL |
Why free PSA matters: Prostate cancer cells produce more PSA that binds tightly to blood proteins (primarily alpha-1-antichymotrypsin). Benign prostate tissue releases more unbound, free PSA. This means:
- Cancer → more bound PSA → lower % free PSA
- BPH → more free PSA → higher % free PSA
The % free PSA calculation exploits this difference to improve discrimination between cancer and benign disease in the gray zone where total PSA alone cannot reliably distinguish the two.
WHAT DOES LOW % FREE PSA MEAN?
A low % free PSA — below 10–15%, depending on the lab and clinical context — means a smaller proportion of your total PSA is circulating free (unbound). This pattern is more commonly seen with prostate cancer than with benign prostate conditions.
Important clarification: "Low free PSA" in the clinical sense means a low percentage, not a low absolute number. If your report says "PSA Free 0.3 ng/mL" with a total PSA of 3.0 ng/mL, the % free PSA is 10% — which is low as a ratio even though the absolute value 0.3 looks small.
What to do with low % free PSA:
- Discuss the finding with your urologist alongside total PSA, age, DRE, and prior PSA history
- Consider prostate MRI to look for lesions that warrant targeted biopsy
- Do not make clinical decisions based on % free PSA alone
WHAT DOES HIGH % FREE PSA MEAN?
A high % free PSA — above 25% — suggests that most of your PSA is circulating in the free (unbound) form. This pattern is more commonly associated with benign prostate conditions such as BPH.
High % free PSA does not rule out prostate cancer entirely — cancer can still be present. But it indicates that the probability is lower than in men with the same total PSA and a lower % free PSA.
Common causes of high % free PSA:
- Benign prostatic hyperplasia (BPH) — the most common cause
- Prostatitis or prostate inflammation
- Normal variation
- Benign prostate disease in general
If total PSA is also elevated alongside a high % free PSA, monitoring rather than immediate biopsy is often the appropriate approach — but always with urologist guidance.
NON-CANCER CAUSES OF ELEVATED TOTAL PSA (CONTEXT FOR % FREE PSA)
Because % free PSA is interpreted alongside total PSA, understanding what raises total PSA matters:
- BPH — enlarged prostate produces more PSA
- Prostatitis — prostate infection or inflammation raises PSA significantly and transiently
- Recent ejaculation — can transiently raise PSA; most guidelines recommend a 24–48 hour abstention before PSA testing
- Prostate manipulation — catheterisation, cystoscopy, prostate massage raise PSA
- Vigorous cycling — documented to modestly raise PSA through perineal pressure
- Urinary tract infection (UTI) — can raise PSA transiently
These non-cancer causes tend to raise both free and bound PSA somewhat proportionally — so % free PSA may be less affected than total PSA by these confounders.
COMMON PHRASES SEEN ON LAB REPORTS
PSA, % FREE PSA % FREE PSA, % FREE (CALC) PSA FREE PCT PSA FREE PCT LOW PSA FREE PERCENTAGE % FREE PSA PERCENT FREE PSA FREE PSA FREE PSA PERCENTAGE FREE/TOTAL PSA RATIO PSA FREE/TOTAL RATIO FREE PSA INDEX PSA FREE 14L / PSA FREE 14 PSA FREE 17 / PSA FREE 17L PSA FREE 18 / PSA FREE 18L PSA FREE 20L / PSA FREE 20 PSA FREE 25L / PSA FREE 25 PSA FREE 0.1 / PSA FREE 0.3 / PSA FREE 0.4 [absolute ng/mL values] PSA FREE LOW PSA, FREE [absolute free PSA in ng/mL — different from % free] PSA, FREE NG/ML PSA FREE AND TOTAL PSA SCORE FREE TOTAL PERCENTAGE F-PSA / fPSA PSA LIBRE / PSA LIBRE TOTAL (Spanish) PSA LIBER / RAPORT PSA LIBER (Romanian) SERBEST PSA / SERBEST PSA/TOTAL PSA ORANI (Turkish) PSA LIBERO / PSA LIBERO TOTALE (Italian) FREE PSA / TOTAL PSA RATIO تحليل (Arabic)
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →Frequently Asked Questions
What is the normal range for free PSA by age?
What does "PSA free 14L" mean?
What does "PSA free 20L" mean?
What does "PSA free 17" or "PSA free 18" mean?
What does "PSA free 25L" mean?
What does low % free PSA mean?
What is the difference between free PSA and total PSA?
What does PSA free PCT mean?
How is % free PSA calculated?
What does PSA free 0.1 or PSA free 0.3 mean?
At what % free PSA should I consider a biopsy?
What does serbest PSA / PSA total oranı mean? (Turkish)
What does free PSA / PSA libre / PSA libre total mean? (Spanish)
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.
-
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial
-
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study
-
Screening Tests for Prostate Cancer
-
AUA Guidelines for Screening of Prostate Cancer 2023
-
Prostate-specific Antigen (PSA), Free:Total Ratio Reflex